Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

AngioDynamics Q1 Adj. EPS $(0.10) Beats $(0.12) Estimate, Sales $75.711M Beat $72.725M Estimate

Author: Benzinga Newsdesk | October 02, 2025 06:03am
AngioDynamics (NASDAQ:ANGO) reported quarterly losses of $(0.10) per share which beat the analyst consensus estimate of $(0.12) by 14.53 percent. This is a 9.09 percent increase over losses of $(0.11) per share from the same period last year. The company reported quarterly sales of $75.711 million which beat the analyst consensus estimate of $72.725 million by 4.11 percent. This is a 12.18 percent increase over sales of $67.491 million the same period last year.

Posted In: ANGO


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist